Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Reece, I. J
Right arrow Articles by Sheth, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reece, I. J
Right arrow Articles by Sheth, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Blood Thinners
Hazardous Substances DB
*HEPARIN
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The activated clotting time loading dose response ratio (ACTLORR) as an indicator of heparin demand during cardiopulmonary bypass

Ian J Reece

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Gerrard Linley

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Habib Al Tareif

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Rollie DeVroege

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Jitesh Tolia

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Jayesh Sheth

The Mohammad bin Khalifa bin Sulman AI Khalifa Cardiac Centre, Bahrain

Data relating to the activated clotting time response to a 4 mg/kg heparin loading dose were collected prospectively in 358 patients having cardio pulmonary bypass. After excluding patients with factors known to cause relative heparin resistance or sensitivity, the activated clotting time (ACT) loading dose response ratio (ACTLORR) was calculated retrospectively in 263 patients and found to correlate significantly (p = 0.0001) with the need for extra heparin administration during bypass. Where the ACTLORR was above 5.5, 92% of patients required no additional heparin during the first 90 minutes of bypass (n = 98). Where the ACTLORR was between 4.0 and 5.0, it was far less predictive, with approximately 35% of patients requiring additional heparin.

This study indicates that a large ACT response to the initial heparin loading dose (a high ACTLORR) is predictive of stable, adequate anticoagulation during the first 90 minutes of bypass, but that a low initial response is not necessarily associated with declining ACTs and the need for additional heparin administration.

Perfusion, Vol. 11, No. 2, 125-130 (1996)
DOI: 10.1177/026765919601100206


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?